可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] Roig E, Perez VF, Morales M. Clinical implications of increased plasma angitgensinⅡdespite ACE inhibitor therapy in patients with congestive heart failure[J].Eur Heart J,2000,21:53-57 .
[2] Jorde UP, Ennezat PV,Lisker BA. Maximally recommended doses of angiotensin converting enzyme inhibitors do not completely prevent ACE-mediated formation of angiotensinⅡin chronic heart failure[J].Circulation,2000,101:844-846.
[3] Rocca HP, Weilenmann D,Kiowski W.Within-patient comparison of effects of different dosages of enalapril on functional capacity and neurohormonal levels in patients with chronic heart failure[J].Am Heart J,1999,138:654-662
[4] Gullestad L,Aukrust P, Ueland T.Effects of high-versus low-dose angiotensin converting enzyme inhibitor on cytokine levels in chronic heart failure[J].J Am Coll Cardiol,1999,34:2061-2067..
[5] Clement DL,De Buyxere M,Tomas M,et al. Long-term effects of clinical outcome with low and high dose in the captopril in heart insufficient patients study[J].Acta Cardiol, 2000, 55(1):1-7.
[6] Pacher M, Poole-Wilson PA, Armstrong PW.Comparative effects of low and high doses of the angiotensin converting enzyme inhibitor,lisinopril,on mortality in chronic heart failure
[J].Circulation,1999,100:2312-2318.
[7] Massie MB,Armstrong PW,Clcland JGF. Tolerance of highversus low-dose angiotensin converting enzyme inhibitor in chronic heart failure[J].Arch Intern Med,2001,161:165-171